Merck sues to challenge new US drug price program

Merck filed a lawsuit Tuesday challenging a new White House-backed program to limit drug prices, calling the initiative an unconstitutional “extortion” that will harm pharmaceutical innovation. President Joe Biden has touted the Medicare Drug Price Negotiation Program, which allows the Medicare health program to negotiate prices for costly drugs made by a single producer. But pharmaceutical giant Merck, in a […]

Continue reading »

Controlling and recording brain activity with infrared flexible optoelectronic fibers

Optogenetics and infrared neurostimulation (INS) constitutes a powerful toolbox in neuroscience to study and control neuronal activity using light. The latter optical method (INS) is recently gaining momentum as a transgene-free optical technique to investigate both the central and peripheral nervous system and therefore constitutes a promising therapeutic approach for neurological and neurodegenerative diseases. Until now, soft, biocompatible infrared fiber-based […]

Continue reading »

Blood Biomarker May Help Predict Who Will Develop AD

A blood biomarker that measures astrocyte reactivity may help determine who, among cognitively unimpaired older adults with amyloid-beta, will go on to develop Alzheimer’s disease (AD), new research suggests. Investigators tested the blood of 1000 cognitively healthy individuals with, and without, amyloid-beta pathology and found that only those with a combination of amyloid-beta burden and abnormal astrocyte activation subsequently progressed […]

Continue reading »

Gonorrhoea and syphilis cases in England reach record highs – latest data

Gonorrhoea: The facts and how to prevent the infection New data suggests there were a whopping 392,453 sexually transmitted infections (STIs) reported in England last year, which is more than 1,000 STI diagnoses every day. The number of gonorrhoea and syphilis diagnoses were driving this peak. Figures from the UK’s Health Security Agency (UKHSA) found that gonorrhoea diagnoses increased by […]

Continue reading »

A simple blood test can diagnose neurometabolic condition, De Vivo disease

Thanks to the collaboration between teams from the AP-HP, the MedTech METAFORA biosystems, the Institute of Molecular Genetics of Montpellier, Cerba Healthcare, and more than 30 investigating centers coordinated by Professor Fanny Mochel at Paris Brain Institute, a reliable and rapid blood test now enables early diagnosis of Glut1 deficiency syndrome, or De Vivo disease—a rare and yet treatable neurometabolic […]

Continue reading »
1 2 3 875